Literature DB >> 20299432

Comparative studies of different gadolinium agents in brain tumors: differences between gadolinium chelates and their possible influence on imaging features.

N Anzalone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20299432      PMCID： PMC7963946          DOI： 10.3174/ajnr.A2068

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  10 in total

1.  Gadobutrol, a highly concentrated MR-imaging contrast agent: its physicochemical characteristics and the basis for its use in contrast-enhanced MR angiography and perfusion imaging.

Authors:  Alexander Huppertz; Martin Rohrer
Journal:  Eur Radiol       Date:  2004-05       Impact factor: 5.315

2.  Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Authors:  Thomas Grobner
Journal:  Nephrol Dial Transplant       Date:  2006-01-23       Impact factor: 5.992

3.  Contrast-enhanced MR imaging of brain lesions: a large-scale intraindividual crossover comparison of gadobenate dimeglumine versus gadodiamide.

Authors:  H A Rowley; G Scialfa; P-y Gao; J A Maldjian; D Hassell; M J Kuhn; F J Wippold; M Gallucci; B C Bowen; I M Schmalfuss; J Ruscalleda; S Bastianello; C Colosimo
Journal:  AJNR Am J Neuroradiol       Date:  2008-07-03       Impact factor: 3.825

4.  Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents.

Authors:  Kenneth R Maravilla; Joseph A Maldjian; Ilona M Schmalfuss; Matthew J Kuhn; Brian C Bowen; Franz J Wippold; Val M Runge; Michael V Knopp; Stephane Kremer; Leo J Wolansky; Nicoletta Anzalone; Marco Essig; Lars Gustafsson
Journal:  Radiology       Date:  2006-06-26       Impact factor: 11.105

5.  Diagnostic yield of double-dose gadobutrol in the detection of brain metastasis: intraindividual comparison with double-dose gadopentetate dimeglumine.

Authors:  E S Kim; J H Chang; H S Choi; J Kim; S-K Lee
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-28       Impact factor: 3.825

6.  Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions.

Authors:  Ender Uysal; Sukru Mehmet Erturk; Hakan Yildirim; Feray Seleker; Muzaffer Basak
Journal:  AJR Am J Roentgenol       Date:  2007-03       Impact factor: 3.959

7.  Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine.

Authors:  Nicoletta Anzalone; Simonetta Gerevini; Roberta Scotti; Paolo Vezzulli; Piero Picozzi
Journal:  Acta Radiol       Date:  2009-10       Impact factor: 1.990

8.  In vivo measurement of gadolinium concentration in a rat glioma model by monochromatic quantitative computed tomography: comparison between gadopentetate dimeglumine and gadobutrol.

Authors:  Géraldine Le Duc; Stéphanie Corde; Anne-Marie Charvet; Hélène Elleaume; Régine Farion; Jean-François Le Bas; François Estève
Journal:  Invest Radiol       Date:  2004-07       Impact factor: 6.016

9.  Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions.

Authors:  Martin A Sieber; Philipp Lengsfeld; Thomas Frenzel; Sven Golfier; Heribert Schmitt-Willich; Fred Siegmund; Jakob Walter; Hanns-Joachim Weinmann; Hubertus Pietsch
Journal:  Eur Radiol       Date:  2008-06-11       Impact factor: 5.315

10.  Multicenter, double-blind, randomized, intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine in MRI of brain tumors at 3 tesla.

Authors:  Zoran Rumboldt; Howard A Rowley; Fred Steinberg; Joseph A Maldjian; Jordi Ruscalleda; Lars Gustafsson; Stefano Bastianello
Journal:  J Magn Reson Imaging       Date:  2009-04       Impact factor: 4.813
  10 in total
  4 in total

Review 1.  MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice.

Authors:  M Essig; N Anzalone; S E Combs; À Dörfler; S-K Lee; P Picozzi; A Rovira; M Weller; M Law
Journal:  AJNR Am J Neuroradiol       Date:  2011-10-20       Impact factor: 3.825

2.  Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study).

Authors:  Z Seidl; J Vymazal; M Mechl; M Goyal; M Herman; C Colosimo; M Pasowicz; R Yeung; B Paraniak-Gieszczyk; B Yemen; N Anzalone; A Citterio; G Schneider; S Bastianello; J Ruscalleda
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-01       Impact factor: 3.825

3.  Dynamic and static magnetic resonance angiography of the supra-aortic vessels at 3.0 T: intraindividual comparison of gadobutrol, gadobenate dimeglumine, and gadoterate meglumine at equimolar dose.

Authors:  Jens Harald Kramer; Elisabeth Arnoldi; Christopher J François; Andrew L Wentland; Konstantin Nikolaou; Bernd J Wintersperger; Thomas M Grist
Journal:  Invest Radiol       Date:  2013-03       Impact factor: 6.016

Review 4.  Contrast-enhanced magnetic resonance imaging in pediatric patients: review and recommendations for current practice.

Authors:  Ravi Bhargava; Gabriele Hahn; Wolfgang Hirsch; Myung-Joon Kim; Hans-Joachim Mentzel; Oystein E Olsen; Eira Stokland; Fabio Triulzi; Elida Vazquez
Journal:  Magn Reson Insights       Date:  2013-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.